Entasis Therapeutics Holdings Inc.
ETTX
ETTX was delisted on the 8th of July, 2022.
25 hedge funds and large institutions have $11.1M invested in Entasis Therapeutics Holdings Inc. in 2020 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 16 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 3
17% less funds holding
Funds holding: 30 → 25 (-5)
31% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 16
44% less capital invested
Capital invested by funds: $19.6M → $11.1M (-$8.55M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$522K |
| 2 |
VF
Virtu Financial
New York
|
+$238K |
| 3 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$182K |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$168K |
| 5 |
Squarepoint
New York
|
+$117K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$7.16M |
| 2 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$2.35M |
| 3 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$2.06M |
| 4 |
CCM
CAAS Capital Management
New York
|
-$1.18M |
| 5 |
Blackstone Inc
New York
|
-$1.16M |
ETTX Hedge Fund Activity: Q4 2020 in Review
25 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Entasis Therapeutics Holdings Inc. (ETTX) for Q4 2020, worth a combined $11.1M — down 44% from $19.6M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of ETTX and 11 opened new positions — a net loss of 5 holders — while 3 trimmed existing stakes and 6 added.
The largest buyer was Renaissance Technologies, adding an estimated $522K. The largest seller was Armistice Capital, exiting entirely with an estimated $7.16M sold.
- 25 institutional investors held Entasis Therapeutics Holdings Inc. (ETTX) as of Q4 2020, down from 30 in Q3 2020.
- Funds reported $11.1M of Entasis Therapeutics Holdings Inc. stock for Q4 2020, down 44% quarter-over-quarter.
- 11 funds opened new Entasis Therapeutics Holdings Inc. positions in Q4 2020 and 16 closed out, a net change of -5 holders.
- The largest Entasis Therapeutics Holdings Inc. buyer in Q4 2020 was Renaissance Technologies, an estimated $522K added.
- The largest Entasis Therapeutics Holdings Inc. seller in Q4 2020 was Armistice Capital, an estimated $7.16M sold.
Based on aggregated 13F filings for Q4 2020.